UGT1A6B Inhibitors

Chemical inhibitors of UGT1A6B can exert their inhibitory effects through various modes of action, essentially impeding the glucuronidation activity that is characteristic of this protein. Flavonoids like Chrysin and Naringenin, for instance, inhibit UGT1A6B by directly binding to the substrate-binding site, which prevents the substrates from accessing the active site required for the glucuronidation process. This occupation of the binding site by Chrysin or Naringenin precludes the necessary catalytic activity from occurring. Similarly, Biochanin A and Baicalein achieve inhibition by interacting with the catalytic domain of UGT1A6B, thereby hindering the enzymatic activity. Baicalein, by binding to the active site, obstructs the necessary interaction between UGT1A6B and its substrates, leading to a decrease in enzyme activity.

Further, compounds like Quercetin and Myricetin demonstrate their inhibitory action by non-competitive mechanisms. Quercetin binds to a site on UGT1A6B that is distinct from the substrate binding site, which results in an alteration of the enzyme's conformation. This conformational change reduces the overall enzymatic activity of UGT1A6B. Myricetin, on the other hand, forms a complex with UGT1A6B that diminishes the enzyme's affinity for its substrates, leading to a reduced glucuronidation process. Curcumin inhibits UGT1A6B by a similar mode, binding to the enzyme and blocking the active site which is crucial for the enzyme's function. Wogonin and Emodin also inhibit UGT1A6B by binding directly to the enzyme. In the case of Wogonin, the binding is likely altering the tertiary structure of UGT1A6B, which impairs its catalytic activity, whereas Emodin interferes explicitly with the glucuronidation process. Ellagic Acid and Genistein round out the list of inhibitors by engaging in direct interactions with UGT1A6B that lead to a reduction in the enzyme's activity. Ellagic Acid achieves this by binding and preventing proper enzyme function, while Genistein binds to UGT1A6B, thereby preventing the binding of substrates that are necessary for glucuronidation to take place. Each of these chemicals employs a distinct inhibitory mechanism, but all lead to a decreased function of UGT1A6B.